GSK CEO says significant interest in auction of mature drugs
July 23, 2014 at 07:47 AM EDT
LONDON, July 23 (Reuters) - GlaxoSmithKline has seen "very significant" interest from mid-sized pharmaceutical companies and private equity firms in acquiring a range of older drugs that it plans to divest, the drugmaker's chief executive said on Wednesday.
